Diabetes mellitus (DM) increases risk for pulmonary tuberculosis (TB) and adverse treatment
outcomes. Systemic hyper-inflammation is characteristic in people with TB and concurrent …

Background and objective With the colliding global epidemics of diabetes mellitus (DM) and
tuberculosis (TB), we studied the effects of DM on the presentation of TB and its response to …

Comorbid diabetes mellitus (DM) increases tuberculosis (TB) risk and adverse outcomes but
the pathological interactions between DM and TB remain incompletely understood. We …

Background Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …

Objectives Whether diabetes mellitus (DM) increases tuberculosis (TB) recurrence risk is
debatable. We determined the effect of DM on TB recurrence. Methods This retrospective …

We are approaching a day and age where the terms communicable and noncommunicable
diseases are taking on a new meaning. In the epidemiology and global public health space …

Background Diabetes mellitus (DM) increases the risk of tuberculosis (TB) disease.
Knowledge of the impact of DM on TB treatment outcomes is primarily based on …

Background To assess the influence of diabetes mellitus (DM), glycemic control, and
diabetes-related comorbidities on manifestations and outcome of treatment of pulmonary …

The aim of this study was to investigate the association between diabetes mellitus (DM) and
tuberculosis (TB) relapse using the nationwide TB registry in Taiwan. We conducted a case …

Perturbations in CD 4+ and CD 8+ T‐cell phenotype and function are hallmarks of
tuberculosis–diabetes co‐morbidity. However, their contribution to the pathogenesis of this …